BRIACELL THERAPEUTICS CORP. (BCTXL) Operating income 2021–2026
BRIACELL THERAPEUTICS CORP. (BCTXL) annual operating income history from SEC filings — each fiscal year as reported.
-$36.1MFY2026 · since FY2021: -$7.0M → -$36.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$36.1M | -32.5% |
| FY2025 | -$27.2M | +18.4% |
| FY2024 | -$33.3M | -43.2% |
| FY2023 | -$23.3M | -52.2% |
| FY2022 | -$15.3M | -119.2% |
| FY2021 | -$7.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BCTXL financial trends
BCTXL RevenueBCTXL Net incomeBCTXL Net marginBCTXL Gross profitBCTXL Gross marginBCTXL Operating marginBCTXL Operating cash flowBCTXL Free cash flowBCTXL Capital expendituresBCTXL Return on equityBCTXL Stock buybacksBCTXL Dividends paidBCTXL Total assetsBCTXL Total liabilitiesBCTXL Shareholders’ equityBCTXL overview →